G. N. İNANÇ Et Al. , "‘‘Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib," Annual European Congress of Rheumatology , KOPENHAG, Denmark, 2022
İNANÇ, G. N. Et Al. 2022. ‘‘Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib. Annual European Congress of Rheumatology , (KOPENHAG, Denmark).
İNANÇ, G. N., ABACAR, K., ÖZTÜRK, M. A., TUFAN, A., KARADENİZ, H., SARI, İ., ... CAN, G.(2022). ‘‘Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib . Annual European Congress of Rheumatology, KOPENHAG, Denmark
İNANÇ, GÜZİDE Et Al. "‘‘Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib," Annual European Congress of Rheumatology, KOPENHAG, Denmark, 2022
İNANÇ, GÜZİDE N. Et Al. "‘‘Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib." Annual European Congress of Rheumatology , KOPENHAG, Denmark, 2022
İNANÇ, G. N. Et Al. (2022) . "‘‘Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib." Annual European Congress of Rheumatology , KOPENHAG, Denmark.
@conferencepaper{conferencepaper, author={GÜZİDE NEVSUN İNANÇ Et Al. }, title={‘‘Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib}, congress name={Annual European Congress of Rheumatology}, city={KOPENHAG}, country={Denmark}, year={2022}}